You are here: Industry Insights > CDMO

News List

AGC Biologics to Expand Biopharmaceutical CDMO Capacity prnasia
December 01, 2020
AGC Biologics announced that it will increase the production capacity of its Copenhagen facility. AGC Biologics will construct a new building on land adjacent to its current Copenhagen site, adding production floors with 2000L single-use bioreactors ...
August Bioservices Expands Operations in Nashville contractpharma
November 23, 2020
Tennessee governor Bill Lee, Department of Economic and Community Development commissioner Bob Rolfe, and August Bioservices LLC officials have announced that the August Bioservices will significantly expand its operations in Nashville.
Asahi Kasei Pharma Contracts ProBioGen contractpharma
November 20, 2020
ProBioGen AG has closed a master service agreement with Asahi Kasei Pharma. As a CDMO in high-tier cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the CHO.
COVID-19 is benefiting contract manufacturing services, suggest reports europeanpharmaceuticalreview
November 19, 2020
Reports have found that the COVID-19 pandemic is providing new opportunities for contract and development manufacturing organisations (CDMOs).
Bionova Scientific Secures First Client Commitment contractpharma
November 19, 2020
Bionova Scientific, a biologics CDMO with extensive protein production, cell line development, process development and analytical expertise, has secured its first client commitment for GMP clinical supply.
Cambrex Expands API Mfg. Capacity in Charles City contractpharma
November 18, 2020
Cambrex is expanding its mid-scale and large-scale API manufacturing capacity in Charles City, Iowa. The $50+ million investment aims to meet growing demand for small molecule drug substance development and manufacturing.
Vibalogics Establishes U.S. Presence contractpharma
November 17, 2020
Vibalogics, a global contract development and manufacturing organization (CDMO), has initiated Phase I of its planned $150 million investment in a late-phase clinical and commercial virotherapy manufacturing facility near Boston, MA.
AzurRx BioPharma Partners with Asymchem contractpharma
November 13, 2020
Will develop and produce MS1819 for the treatment of exocrine pancreatic insufficiency.
Porton Biologics Launches Gene and Cell Therapy CDMO Platform contractpharma
November 06, 2020
Commercial manufacturing base settled in Suzhou BioBAY for the development of pharmaceuticals.
COVID-19 is driving more supplier redundancy expresspharma
November 06, 2020
Contract development and manufacturing organisations (CDMOs) are busier than ever, and their work will increase as the pandemic prompts pharma companies to increase redundancy in the supply chain, says GlobalData.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page